Literature DB >> 12467589

Adenosine: a neuron-glial transmitter promoting myelination in the CNS in response to action potentials.

Beth Stevens1, Stefania Porta, Laurel L Haak, Vittorio Gallo, R Douglas Fields.   

Abstract

Neuronal activity influences myelination of the brain, but the molecular mechanisms involved are largely unknown. Here, we report that oligodendrocyte progenitor cells (OPCs) express functional adenosine receptors, which are activated in response to action potential firing. Adenosine acts as a potent neuron-glial transmitter to inhibit OPC proliferation, stimulate differentiation, and promote the formation of myelin. This neuron-glial signal provides a molecular mechanism for promoting oligodendrocyte development and myelination in response to impulse activity and may help resolve controversy on the opposite effects of impulse activity on myelination in the central and peripheral nervous systems.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12467589      PMCID: PMC1201407          DOI: 10.1016/s0896-6273(02)01067-x

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  51 in total

1.  Control of myelination by specific patterns of neural impulses.

Authors:  B Stevens; S Tanner; R D Fields
Journal:  J Neurosci       Date:  1998-11-15       Impact factor: 6.167

2.  Expression of the green fluorescent protein in the oligodendrocyte lineage: a transgenic mouse for developmental and physiological studies.

Authors:  Xiaoqing Yuan; Ramesh Chittajallu; Shibeshih Belachew; Stacie Anderson; Chris J McBain; Vittorio Gallo
Journal:  J Neurosci Res       Date:  2002-11-15       Impact factor: 4.164

3.  Tissue culture studies of interactions between axons and myelinating cells of the central and peripheral nervous system.

Authors:  R P Bunge; P M Wood
Journal:  Prog Brain Res       Date:  1987       Impact factor: 2.453

4.  Developmental and growth factor-induced regulation of nestin in oligodendrocyte lineage cells.

Authors:  V Gallo; R C Armstrong
Journal:  J Neurosci       Date:  1995-01       Impact factor: 6.167

5.  Release of adenosine, inosine and hypoxanthine from rabbit non-myelinated nerve fibres at rest and during activity.

Authors:  J C Maire; J Medilanski; R W Straub
Journal:  J Physiol       Date:  1984-12       Impact factor: 5.182

6.  Thyroid hormone activates oligodendrocyte precursors and increases a myelin-forming protein and NGF content in the spinal cord during experimental allergic encephalomyelitis.

Authors:  Laura Calza; Mercedes Fernandez; Alessandro Giuliani; Luigi Aloe; Luciana Giardino
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

7.  An analysis of the early events when oligodendrocyte precursor cells are triggered to differentiate by thyroid hormone, retinoic acid, or PDGF withdrawal.

Authors:  Y M Tokumoto; B Durand; M C Raff
Journal:  Dev Biol       Date:  1999-09-15       Impact factor: 3.582

8.  Calcium signaling in cultured rat oligodendrocytes.

Authors:  M Takeda; D J Nelson; B Soliven
Journal:  Glia       Date:  1995-07       Impact factor: 7.452

9.  Notch receptor activation inhibits oligodendrocyte differentiation.

Authors:  S Wang; A D Sdrulla; G diSibio; G Bush; D Nofziger; C Hicks; G Weinmaster; B A Barres
Journal:  Neuron       Date:  1998-07       Impact factor: 17.173

10.  A role for glutamate and its receptors in the regulation of oligodendrocyte development in cerebellar tissue slices.

Authors:  X Yuan; A M Eisen; C J McBain; V Gallo
Journal:  Development       Date:  1998-08       Impact factor: 6.868

View more
  194 in total

1.  Nonsynaptic communication through ATP release from volume-activated anion channels in axons.

Authors:  R Douglas Fields; Yingchun Ni
Journal:  Sci Signal       Date:  2010-10-05       Impact factor: 8.192

Review 2.  Axonal signals and oligodendrocyte differentiation.

Authors:  Maura Bozzali; Lawrence Wrabetz
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

3.  NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes.

Authors:  Jonah R Chan; Trent A Watkins; José M Cosgaya; ChunZhao Zhang; Lian Chen; Louis F Reichardt; Eric M Shooter; Ben A Barres
Journal:  Neuron       Date:  2004-07-22       Impact factor: 17.173

4.  Functional holography of recorded neuronal networks activity.

Authors:  Itay Baruchi; Eshel Ben-Jacob
Journal:  Neuroinformatics       Date:  2004

5.  Axon myelination and electrical stimulation in a microfluidic, compartmentalized cell culture platform.

Authors:  In Hong Yang; Devin Gary; Misti Malone; Stephen Dria; Thierry Houdayer; Visar Belegu; John W McDonald; Nitish Thakor
Journal:  Neuromolecular Med       Date:  2012-04-13       Impact factor: 3.843

Review 6.  Purinergic trophic signalling in glial cells: functional effects and modulation of cell proliferation, differentiation, and death.

Authors:  Davide Lecca; Stefania Ceruti; Marta Fumagalli; Maria P Abbracchio
Journal:  Purinergic Signal       Date:  2012-04-12       Impact factor: 3.765

7.  Inhibition of myelin membrane sheath formation by oligodendrocyte-derived exosome-like vesicles.

Authors:  Mostafa Bakhti; Christine Winter; Mikael Simons
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

8.  Oligodendrocyte lineage cells contribute unique features to Rett syndrome neuropathology.

Authors:  Minh Vu Chuong Nguyen; Christy A Felice; Fang Du; Matthew V Covey; John K Robinson; Gail Mandel; Nurit Ballas
Journal:  J Neurosci       Date:  2013-11-27       Impact factor: 6.167

Review 9.  Electrophysiological properties of NG2(+) cells: Matching physiological studies with gene expression profiles.

Authors:  Valerie A Larson; Ye Zhang; Dwight E Bergles
Journal:  Brain Res       Date:  2015-09-15       Impact factor: 3.252

10.  Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: a novel perspective for seizure control.

Authors:  Gaoying Ren; Tianfu Li; Jiang Quan Lan; Andrew Wilz; Roger P Simon; Detlev Boison
Journal:  Exp Neurol       Date:  2007-08-02       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.